EarlyDiagnostics Inc, based in Los Angeles, CA, is a leading provider of accurate and affordable liquid biopsy tests for early cancer detection and precision medicine. Their innovative technologies, including cfMethyl-seq and cfSNV, enable the detection and location of cancer with high accuracy and sensitivity. EarlyDiagnostics also offers a comprehensive bioinformatics solution, EarlyDx-Cloud, which supports diagnostic companies in offering liquid biopsy tests for cancer detection, therapy selection, and treatment monitoring.
With a focus on big data for better diagnosis, EarlyDiagnostics is committed to revolutionizing cancer detection through their experimental and computational innovations. Their team of experts challenges established thinking and drives transformation in the field of cancer diagnostics. Through their dedication to providing non-invasive tests and leveraging the power of innovation, EarlyDiagnostics aims to make a significant impact in the early detection and management of cancer.
Generated from the website